Cite
HARVARD Citation
Gershlick, A. et al. (1994). Failure of epoprostenol (prostacyclin, PGI2) to inhibit platelet aggregation and to prevent restenosis after coronary angioplasty: results of a randomised placebo controlled trial.. Heart. 71 (1), pp. 7-15. [Online].